Page last updated: 2024-08-17

ethinyl estradiol and vx-770

ethinyl estradiol has been researched along with vx-770 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chavan, AB; Dubey, N; Gilmartin, GS; Higgins, M; Li, C; Luo, X; Mahnke, L; Robertson, SM1
Agarwal, S; Garg, V; Gebre, A; Han, L; Huang, J; Jiang, L; Lekstrom-Himes, J; Li, C; Robertson, S; Shen, J; Stephan, K; Wang, LT1
Hussar, DA1

Trials

2 trial(s) available for ethinyl estradiol and vx-770

ArticleYear
Clinical drug-drug interaction assessment of ivacaftor as a potential inhibitor of cytochrome P450 and P-glycoprotein.
    Journal of clinical pharmacology, 2015, Volume: 55, Issue:1

    Topics: Adolescent; Adult; Aminophenols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Contraceptives, Oral, Combined; Cross-Over Studies; Cytochrome P-450 CYP3A Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Digoxin; Double-Blind Method; Drug Interactions; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Midazolam; Middle Aged; Norethindrone; Progesterone; Quinolones; Rosiglitazone; Thiazolidinediones; Young Adult

2015
Pharmacokinetic and Drug-Drug Interaction Profiles of the Combination of Tezacaftor/Ivacaftor.
    Clinical and translational science, 2019, Volume: 12, Issue:3

    Topics: Adolescent; Adult; Aminophenols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benzodioxoles; Ciprofloxacin; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Indoles; Male; Middle Aged; Quinolones; Young Adult

2019

Other Studies

1 other study(ies) available for ethinyl estradiol and vx-770

ArticleYear
New drugs 2020, part 3.
    Nursing, 2020, Volume: 50, Issue:10

    Topics: Aminophenols; Antibodies, Monoclonal, Humanized; Azabicyclo Compounds; Benzodioxoles; beta-Cyclodextrins; Cilastatin; Drug Approval; Drug Combinations; Ethinyl Estradiol; Genetic Vectors; Humans; Imipenem; Indoles; Nitroimidazoles; Pregnanolone; Pregnenediones; Pyrazoles; Pyridines; Pyrrolidines; Quinolones; Retinoids; United States; United States Food and Drug Administration

2020